Business Overview
Westlake Corporation operates as a global manufacturer and supplier of materials and innovative products, serving diverse end-markets that include housing, construction, packaging, healthcare, automotive, and consumer goods. Headquartered in Houston, Texas, the Company maintains a substantial operational footprint spanning across North America, Europe, and Asia. The Company organizes its operations and reports its financial results through two primary segments: Housing and Infrastructure Products (HIP) and Performance and Essential Materials (PEM).
Key Financial Performance Highlights
Net Sales: The Company reported consolidated net sales of $2,533 million in the fourth quarter of 2025. This represents an 11% year-over-year decrease compared to $2,843 million in the fourth quarter of 2024. Sequentially, sales declined from the $2,838 million reported in the third quarter of 2025.
Profitability (GAAP): Westlake recorded a GAAP net loss attributable to the Company of $544 million, translating to a diluted loss of $4.22 per common share. This represents a significant deterioration compared to the net income of $7 million, or $0.06 per share, achieved in the fourth quarter of 2024. The Company’s consolidated EBITDA for the quarter stood at a loss of $315 million.
Impact of “Identified Items”: Fourth-quarter earnings were heavily suppressed by $511 million in combined pre-tax charges related to strategic structural actions. These Identified Items included $393 million in charges associated with the shutdown of three North American chlorovinyls plants and one styrene plant. Furthermore, the Company recorded $102 million in accrued expenses tied to the shutdown of its epoxy site at Pernis, The Netherlands. Lastly, the HIP segment incurred $16 million in restructuring and related expenses, which included a $3 million loss on the sale of a compounding business and $13 million for footprint optimization.
Adjusted Profitability (Non-GAAP): Excluding the effects of the aforementioned Identified Items, the adjusted net loss for the fourth quarter of 2025 was $33 million, or $0.25 per diluted share. Adjusted EBITDA excluding these items was $196 million, reflecting an 8% adjusted EBITDA margin. Comparatively, the fourth quarter of 2024 adjusted net loss was $40 million better, primarily due to the 11% year-over-year decline in net sales and escalated feedstock and energy costs within the PEM division. Sequentially, the adjusted EBITDA of $196 million represented a $117 million decline from the $313 million recorded in the third quarter of 2025.
Full Year 2025 Results
Net Sales: For the full year 2025, consolidated net sales were $11,170 million, down from $12,142 million in 2024.
Profitability (GAAP): Full-year net loss attributable to Westlake was $1,508 million, or a loss of $11.70 per diluted share, a stark reversal from the net income of $602 million ($4.64 per share) in 2024. Loss from operations for the year was $1,578 million, compared to income of $875 million in the prior year.
Full Year Identified Items: The full-year results were significantly skewed by Identified Items, prominently featuring a $727 million non-cash charge for the write-off of all goodwill associated with the North American Chlorovinyls reporting unit.
Adjusted Profitability (Non-GAAP): Excluding Identified Items, the full-year 2025 net loss was $116 million ($0.90 per share), which was $793 million below the adjusted net income of $677 million achieved in 2024. Full-year adjusted EBITDA stood at $1,144 million, generating a 10% margin, compared to an adjusted EBITDA of $2,286 million and a 19% margin in 2024. The overarching declines were attributed to lower average sales prices, depressed sales volumes, heightened energy and feedstock costs, and the amplified impact of both planned turnarounds and unplanned plant outages throughout 2025.
Segment-wise Performance
Housing and Infrastructure Products (HIP)
Net Sales: The HIP segment generated $901 million in net sales during the fourth quarter of 2025, an 8% decrease from $981 million in the fourth quarter of 2024. For the full year, HIP sales totaled $4,148 million, down from $4,317 million in 2024.
Sub-segment Breakdown: Full-year Housing Products sales fell slightly to $3,513 million (down approximately $0.1 billion) primarily due to lower sales volume, specifically in roofing. Infrastructure Products sales declined to $635 million from $673 million in 2024, influenced by lower average sales prices for pipe and fittings and lower global compounds sales volume.
Operating Income and EBITDA: Fourth-quarter income from operations was $66 million, or $82 million excluding Identified Items. This adjusted operating income represented a $47 million year-over-year decrease. Fourth-quarter EBITDA was $130 million, or $146 million excluding restructuring expenses, yielding a 16% adjusted EBITDA margin.
Drivers: The year-over-year operational income decline in Q4 was driven by depressed margins and lower sales volume, particularly in global compounds. Sequentially, Q4 adjusted operating income dropped by $69 million compared to Q3 2025, largely due to typical seasonal weakness in customer demand. Full-year segment operating income contracted by $204 million to $603 million, again pressured by volume weakness in global compounds and margin degradation in pipe and fittings.
Performance and Essential Materials (PEM)
Net Sales: PEM segment sales for Q4 2025 fell 12% year-over-year to $1,632 million, compared to $1,862 million in Q4 2024. Full-year sales for the segment dropped by $0.8 billion to $7,022 million.
Sub-segment Breakdown: Full-year Performance Materials sales were $4,018 million, down $0.6 billion year-over-year, driven by reduced sales volumes and lower average sales prices for polyethylene and PVC resin, alongside diminished epoxy resin volumes. Essential Materials sales were $3,004 million, representing a $0.2 billion decline due to lower chlorine pricing and volume, and lower caustic soda volumes.
Operating Income and EBITDA: The segment recorded a GAAP operating loss of $717 million in Q4 2025. Excluding the massive $495 million in shutdown expenses, the adjusted operating loss was $222 million, representing a steep decline from the $41 million operating loss recorded in Q4 2024. Segment EBITDA was a loss of $450 million; however, excluding Identified Items, EBITDA was $45 million (reflecting a narrow 3% margin).
Drivers: The Q4 year-over-year adjusted operating loss expansion was a direct result of lower selling prices across major product lines—most notably chlorine and polyethylene—combined with lower volume throughput for PVC resin, polyethylene, and epoxy resin. Sequentially, the adjusted operating loss widened by $64 million versus Q3 2025, heavily impacted by deteriorating average sales prices for polyethylene, chlorine, and PVC. Full-year segment performance was further hamstrung by elevated feedstock/energy inputs and increased operational disruptions from outages and turnarounds.
Operational Metrics and Key Drivers
The Company provided granular volume and pricing variance data that outlines the fundamental drivers of the revenue contractions.
Year-over-Year (Q4 2025 vs. Q4 2024): * On a consolidated basis, average sales prices declined by 4% while volume dropped by 7%.
The HIP segment successfully maintained flat pricing (0% variance) but suffered an 8% volume contraction.
The PEM segment faced dual headwinds, reporting a 5% drop in average sales price alongside a 7% decline in volume.
Sequential (Q4 2025 vs. Q3 2025): * Consolidated average sales price dipped by 3% sequentially, coupled with a 7% decline in volume.
HIP experienced intense seasonal volume pressure, recording a 17% sequential drop in volume and a 1% decline in price.
PEM saw a more pronounced sequential price degradation of 5%, while volume fell modestly by 2%.
Cash Flow and Balance Sheet Analysis
Despite the GAAP net losses driven by substantial non-cash impairment and restructuring charges, the Company generated positive cash flow.
Operating Cash Flow: Net cash provided by operating activities was $225 million in the fourth quarter of 2025. For the full twelve-month period of 2025, operating cash flow totaled $465 million, significantly trailing the $1,314 million generated in 2024.
Capital Expenditures and Free Cash Flow: Fourth-quarter capital expenditures were $241 million, resulting in a Free Cash Flow generation of $(16) million. For the full year 2025, capital additions to property, plant, and equipment were $995 million.
Liquidity Position: The Company maintains a well-capitalized balance sheet. As of December 31, 2025, total cash, cash equivalents, and fixed-income available-for-sale securities amounted to approximately $2.9 billion.
Debt Profile: Total debt outstanding as of the end of 2025 stood at $5.6 billion. Financing activities during the year included the issuance of senior notes generating $1,187 million in net proceeds, partially offset by $254 million applied toward the repurchase and redemption of senior notes.
Management Commentary and Strategic Updates
Management’s commentary underscored a transition year focused on structural rightsizing and margin protection amidst a challenging macro environment.
Footprint Optimization: President and CEO Jean-Marc Gilson emphasized that the PEM profitability improvement plan initiated tangible benefits in the fourth quarter, driven by accelerating cost savings and significant strategic actions to optimize the North American operational footprint. Due to these structural adjustments, the adjusted Q4 EBITDA for the PEM division exceeded management’s internal expectations.
HIP Performance: The HIP segment’s performance aligned with management’s expectations, fully reflecting the anticipated headwinds from slower housing starts and seasonal weather conditions.
2026 Strategic Priorities: Looking ahead to 2026, the executive team’s primary priority is executing the PEM profitability improvement plan to achieve a targeted $600 million improvement in EBITDA. Concurrently, the Company seeks to grow sales and earnings in the HIP segment, which is projected to benefit synergistically from the recently completed January 2026 acquisition of ACI.
Macro Outlook: Management remains conservative regarding the external environment, explicitly stating they do not expect macroeconomic conditions to act as a tailwind in 2026 due to persistently challenging global industrial and manufacturing activity. However, they expressed strong confidence in their internal self-help initiatives to structurally improve earnings.
Notable Risks and Challenges
The document highlights several forward-looking risks and systemic challenges inherent in Westlake’s current operational landscape:
Macroeconomic and Trade Environment: The business faces ongoing uncertainties tied to global economic conditions, including political tensions and conflicts in regions such as the Middle East, Russia, and Ukraine. Furthermore, the operations are vulnerable to barriers in international trade, including trade disputes and the potential imposition of tariffs and duties.
Industry Cyclicality and Inputs: The inherent cyclical nature of the chemical and building products industries remains a primary risk factor, compounded by the volatility and cost availability of raw materials and energy inputs.
Demand Shifts and Regulations: Long-term demand for key products like ethylene, polyethylene, and polyvinyl chloride faces risks from climate change initiatives, heightened recycling efforts, and shifting customer preferences toward alternative polymers. Additionally, the Company must navigate current and potential governmental regulatory actions domestically and abroad.
Competitive Dynamics: Supply and demand imbalances for Westlake’s specific products, alongside aggressive competitive pricing pressures from global peers, continue to pose challenges to margin stabilization.
The post Equity Research: Westlake Corporation (WLK) Q4 2025 Results and 2026 Profitability Outlook first appeared on Alphastreet.
